AAO-HNS issues guidance for Bell’s palsy treatment during COVID-19

AstraZeneca vaccine effective against UK variant: Oxford University
5 February 2021
New drug targets for childhood cancer neuroblastoma identified
5 February 2021

AAO-HNS issues guidance for Bell’s palsy treatment during COVID-19

(HealthDay)—In a statement issued by the American Academy of Otolaryngology-Head and Neck Surgery, recommendations are presented for the treatment of Bell’s palsy after COVID-19 vaccination and for unvaccinated patients.

Comments are closed.